c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
CG Oncology (CGON) Reports Positive Phase 3 Trial Data for Bladder Cancer Therapy
GuruFocus | Nov 16, 2026 11:26 AM EST
Related Stocks: CGON ,
Read original article